Detailed information of FOXA1

  1. Home
  2. TF > FOXA1

Dataset summary

TF Name: FOXA1 Species: Homo sapiens
Cell-type/Tissue: K562 (myelogenous leukemia) Condition/Source:
JASPAR ID: MA0148.4 Collections: Permissive Robust
References: ENCODE ENCSR819LHG GEO GSE92078 GTRD EXP039676

External links

Models for profile: MA0148.4

Download TFBSs (hg38)

Download TFBSs in BED and FASTA format

Download trained model

Download trained prediction models

Visualize TFBSs in UCSC

Send TFBSs BED file to UCSC genome browser

Summary plots

Statistical details

Model Peak caller Model ID Enrichment Zone TFBSs Score threshold Centrality p-value (log10)
DAMO MACS MA0148.4 20.5 123 90.9 -33.9494644669881

220 datasets found for the same TF (FOXA1) in other cell-types/tissues

TF Name Cell-line Condition/Source Collections Species Identifiers JASPAR ID
FOXA1 Ishikawa (endometrial adenocarcinoma) 1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers) Permissive Robust Homo sapiens ENCSR000BKW MA0148.4
FOXA1 T47D (invasive ductal carcinoma) 1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers) Permissive Robust Homo sapiens ENCSR000BKY MA0148.4
FOXA1 A549 (lung carcinoma) 1 h with 100 nM Dexamethasone (Myers) Permissive Robust Homo sapiens ENCSR000BPX MA0148.4
FOXA1 A549 (lung carcinoma) 1 h with 0.02% Ethanol (Myers) Permissive Robust Homo sapiens ENCSR000BRD MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) E2 Permissive Robust Homo sapiens GSE26831 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) E2 Permissive Robust Homo sapiens GSE26831 ... MA0148.4
FOXA1 VCaP (prostate carcinoma) regular medium Permissive Robust Homo sapiens GSE14092 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) regular medium Permissive Robust Homo sapiens GSE14092 ... MA0148.4
FOXA1 lung adenocarcinoma Nkx2-1 negative Permissive Robust Mus musculus GSE43252 ... MA0148.4
FOXA1 lung adenocarcinoma Nkx2-1 negative Permissive Robust Mus musculus GSE43252 ... MA0148.4
FOXA1 prostate castrated+vehicle Permissive Robust Mus musculus GSE47192 ... MA0148.4
FOXA1 kidney castrated+testosterone Permissive Mus musculus GSE47192 ... MA0148.4
FOXA1 caput epididymis intact Permissive Mus musculus GSE47192 ... MA0148.4
FOXA1 prostate castrated+testosterone Permissive Robust Mus musculus GSE47192 ... MA0148.4
FOXA1 CyT49-derived endodermal cells none Permissive Robust Homo sapiens GSE54471 ... MA0148.4
FOXA1 CyT49-derived endodermal cells none Permissive Robust Homo sapiens GSE54471 ... MA0148.4
FOXA1 CyT49-derived endodermal cells none Permissive Robust Homo sapiens GSE54471 ... MA0148.4
FOXA1 CyT49-derived endodermal cells none Permissive Robust Homo sapiens GSE54471 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) vehicle, control Permissive Robust Homo sapiens GSE43678 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) 10 nm DHT Permissive Robust Homo sapiens GSE43678 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) shCtrl Permissive Robust Homo sapiens GSE73363 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) shTET1 Permissive Robust Homo sapiens GSE73363 ... MA0148.4
FOXA1 VCaP (prostate carcinoma) none Permissive Robust Homo sapiens GSE77770 ... MA0148.4
FOXA1 VCaP (prostate carcinoma) DHT 10 nM Permissive Robust Homo sapiens GSE77770 ... MA0148.4
FOXA1 MCF-7L (invasive ductal carcinoma) tamoxifen Permissive Robust Homo sapiens GSE75201 ... MA0148.4
FOXA1 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) tamoxifen Permissive Robust Homo sapiens GSE75201 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) No treatment Permissive Robust Homo sapiens GSE81714 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Nonspecific siRNA Permissive Robust Homo sapiens GSE81714 ... MA0148.4
FOXA1 F9 (embryonal carcinoma) treated 48 hrs with RA Permissive Robust Mus musculus GSE82314 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) DMSO Permissive Robust Homo sapiens GSE84593 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) BYL719 Permissive Robust Homo sapiens GSE84593 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) control; 100 nM 17-beta-estradiol for 0h Permissive Robust Homo sapiens GSE85106 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) 100 nM 17-beta-estradiol for 45 min Permissive Homo sapiens GSE85106 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) 100 nM 17-beta-estradiol for 3h Permissive Robust Homo sapiens GSE85106 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) ShMEN1 Permissive Robust Homo sapiens GSE94001 ... MA0148.4
FOXA1 VCaP (prostate carcinoma) siCtl Permissive Robust Homo sapiens GSE96652 ... MA0148.4
FOXA1 VCaP (prostate carcinoma) siERG Permissive Robust Homo sapiens GSE96652 ... MA0148.4
FOXA1 pancreatic ductal adenocarcinoma, liver metastasis Transduced with miR-E/shRen retrovirus Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 pancreatic ductal adenocarcinoma, liver metastasis Transduced with miR-E/shFoxa1.2959 retrovirus Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 cultured pancreatic ductal adenocarcinoma cells Transduced with MSCV/emp retrovirus Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 cultured pancreatic ductal adenocarcinoma cells transduced with MSCV/FOXA1 retrovirus Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Veh_90 Permissive Robust Homo sapiens GSE32222 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Cocktail_90 Permissive Robust Homo sapiens GSE32222 ... MA0148.4
FOXA1 breast tumor Female Permissive Robust Homo sapiens GSE104399 ... MA0148.4
FOXA1 breast tumor Male Permissive Robust Homo sapiens GSE104399 ... MA0148.4
FOXA1 A1-2 (breast cancer cells) Treatment: 1hr EtOH Permissive Homo sapiens GSE112491 ... MA0148.4
FOXA1 A1-2 (breast cancer cells) Treatment: 1hr Dex Permissive Homo sapiens GSE112491 ... MA0148.4
FOXA1 A1A3(breast cancer cells) Treatment: 1hr EtOH, PBS 72 hr CellLine: A1A3 from T47D cell line Permissive Robust Homo sapiens GSE112491 ... MA0148.4
FOXA1 A1A3(breast cancer cells) Treatment: 1hr Dex, PBS 72 hr CellLine: A1A3 from T47D cell line Permissive Robust Homo sapiens GSE112491 ... MA0148.4
FOXA1 A1A3(breast cancer cells) Treatment: 1hr EtOH, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown Permissive Robust Homo sapiens GSE112491 ... MA0148.4
FOXA1 A1A3(breast cancer cells) Treatment: 1hr Dex, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown Permissive Robust Homo sapiens GSE112491 ... MA0148.4
FOXA1 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min 10^-7 4OHT Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min 10^-7 4OHT Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min 10^-7 4OHT Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 WS8 cells Treatment: 45 min 10^-7 4OHT Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 WS8 cells Treatment: 45 min 10^-7 4OHT Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 WS8 cells Treatment: 45 min 10^-7 4OHT Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 WS8 cells Treatment: 45 min 10^-8 E2 Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 WS8 cells Treatment: 45 min 10^-8 E2 Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 WS8 cells Treatment: 45 min 10^-8 E2 Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 WS8 cells Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 WS8 cells Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 WS8 cells Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min 10^-8 E2 Permissive Robust Homo sapiens GSE113092 ... MA0148.4
FOXA1 prostate tumor Patient: #1 Permissive Robust Homo sapiens GSE114385 ... MA0148.4
FOXA1 prostate tumor Patient: #2 Permissive Robust Homo sapiens GSE114385 ... MA0148.4
FOXA1 prostate tumor Patient: #3 Permissive Robust Homo sapiens GSE114385 ... MA0148.4
FOXA1 prostate tumor Patient: #4 Permissive Robust Homo sapiens GSE114385 ... MA0148.4
FOXA1 22RV1 (prostate carcinoma) Treatment: ethanol Permissive Robust Homo sapiens GSE80742 ... MA0148.4
FOXA1 22RV1 (prostate carcinoma) Treatment: R1881 Permissive Robust Homo sapiens GSE80742 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) Treatment: Cells were harvested in log phase growth Genotype: wildtype Permissive Robust Homo sapiens GSE85558 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression Permissive Robust Homo sapiens GSE85558 ... MA0148.4
FOXA1 22RV1 (prostate carcinoma) Treatment: Cells were harvested in log phase growth Genotype: wildtype Permissive Robust Homo sapiens GSE85558 ... MA0148.4
FOXA1 22RV1 (prostate carcinoma) Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G Permissive Robust Homo sapiens GSE85558 ... MA0148.4
FOXA1 RT4 (Bladder carcinoma cells) Treatment: not applicable Stage:adult Tissue: transitional cell papilloma Permissive Robust Homo sapiens GSE86918 ... MA0148.4
FOXA1 RT4 (Bladder carcinoma cells) Treatment: not applicable Stage:adult Tissue: transitional cell papilloma Permissive Robust Homo sapiens GSE86918 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) Treatment: treated with 10nM R1881 for 4 hours Permissive Robust Homo sapiens GSE94682 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) Passsage: <10 Permissive Robust Homo sapiens GSE99479 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) Passsage: <10 Permissive Robust Homo sapiens GSE99479 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) Passsage: <10 Genotype: wt/R330fs mutant with CRISPR Permissive Robust Homo sapiens GSE99479 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) Passsage: <10 Genotype: wt/R330fs mutant with CRISPR Permissive Robust Homo sapiens GSE99479 ... MA0148.4
FOXA1 liver Strain: C57BL/6N Sex: male Permissive Robust Mus musculus GSE106379 ... MA0148.4
FOXA1 liver Strain: C57BL/6N Sex: male Permissive Robust Mus musculus GSE106379 ... MA0148.4
FOXA1 liver Strain: C57BL/6N Sex: male Permissive Robust Mus musculus GSE106379 ... MA0148.4
FOXA1 liver Strain: C3H/HeN Sex: male Permissive Robust Mus musculus GSE106379 ... MA0148.4
FOXA1 liver Strain: C3H/HeN Sex: male Permissive Robust Mus musculus GSE106379 ... MA0148.4
FOXA1 liver Strain: C3H/HeN Sex: male Permissive Robust Mus musculus GSE106379 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) siOCT1 Permissive Robust Homo sapiens GSE77770 ... MA0148.4
FOXA1 LNCaP95 Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection Permissive Robust Homo sapiens GSE106559 ... MA0148.4
FOXA1 LNCaP95 Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection Permissive Robust Homo sapiens GSE106559 ... MA0148.4
FOXA1 LNCaP95 Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection Permissive Robust Homo sapiens GSE106559 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) Treatment: FA (control) Permissive Robust Homo sapiens GSE114737 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) Treatment: 2 mM DSG for 25 mins Permissive Robust Homo sapiens GSE114737 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Treatment: FA (control) Permissive Robust Homo sapiens GSE114737 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Treatment: 2 mM DSG for 25 mins Permissive Robust Homo sapiens GSE114737 ... MA0148.4
FOXA1 primary prostate cancer Treatment: FA (control) Permissive Homo sapiens GSE114737 ... MA0148.4
FOXA1 primary prostate cancer Treatment: 2 mM DSG for 25 mins Permissive Robust Homo sapiens GSE114737 ... MA0148.4
FOXA1 primary breast cancer Treatment: 2 mM DSG for 25 mins Permissive Robust Homo sapiens GSE114737 ... MA0148.4
FOXA1 primary prostate cancer Treatment: 2 mM DSG for 25 mins Permissive Robust Homo sapiens GSE114737 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Treatment: hormone-deprived cells treated with vehicle; Permissive Robust Homo sapiens GSE112969 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins; Permissive Robust Homo sapiens GSE112969 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Treatment: hormone-deprived cells treated with vehicle; Permissive Robust Homo sapiens GSE112969 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins; Permissive Robust Homo sapiens GSE112969 ... MA0148.4
FOXA1 ZR-75-1 (invasive ductal carcinoma) Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins; Permissive Robust Homo sapiens GSE112969 ... MA0148.4
FOXA1 ZR-75-1 (invasive ductal carcinoma) Treatment: hormone-deprived cells treated with vehicle; Permissive Robust Homo sapiens GSE112969 ... MA0148.4
FOXA1 ZR-75-1 (invasive ductal carcinoma) Treatment: hormone-deprived cells treated with vehicle; Permissive Robust Homo sapiens GSE112969 ... MA0148.4
FOXA1 ZR-75-1 (invasive ductal carcinoma) Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins; Permissive Robust Homo sapiens GSE112969 ... MA0148.4
FOXA1 22RV1 (prostate carcinoma) Treatment: DHT10 nM for 24 hrs; Permissive Robust Homo sapiens GSE123565 ... MA0148.4
FOXA1 22RV1 (prostate carcinoma) Treatment: ethanol (Vehicle) treatment for 24 hrs; Permissive Robust Homo sapiens GSE123565 ... MA0148.4
FOXA1 intestinal villus epithelial cells Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background; Permissive Robust Mus musculus GSE111024 ... MA0148.4
FOXA1 intestinal villus epithelial cells Day: 11; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background; Permissive Robust Mus musculus GSE111024 ... MA0148.4
FOXA1 sperm Strain: CD1; Permissive Mus musculus GSE116855 ... MA0148.4
FOXA1 NIH 3T3 (embryonic fibroblasts) Genotype: Overexpression of FOXA1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding; Permissive Robust Mus musculus GSE119782 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) E2_TAM Permissive Robust Homo sapiens ERP000380 MA0148.4
FOXA1 ZR-75-1 (invasive ductal carcinoma) E2_TAM Permissive Robust Homo sapiens ERP000380 MA0148.4
FOXA1 MDA-MB-453 (breast adenocarcinoma) DHT Permissive Robust Homo sapiens GSE45201 MA0148.4
FOXA1 HepG2 (hepatoblastoma) Permissive Robust Homo sapiens ENCSR000BLE MA0148.4
FOXA1 HepG2 (hepatoblastoma) Permissive Robust Homo sapiens ENCSR000BMO MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens ENCSR126YEB MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens GSE26831 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) Permissive Robust Homo sapiens GSE26831 ... MA0148.4
FOXA1 hepatocytes Permissive Robust Mus musculus GSE17067 ... MA0148.4
FOXA1 liver Permissive Robust Mus musculus GSE33666 ... MA0148.4
FOXA1 lung adenocarcinoma Permissive Robust Mus musculus GSE43252 ... MA0148.4
FOXA1 lung adenocarcinoma Permissive Robust Mus musculus GSE43252 ... MA0148.4
FOXA1 LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE72467 ... MA0148.4
FOXA1 HUES64 (embryonic stem cells) Permissive Robust Homo sapiens GSE61475 ... MA0148.4
FOXA1 HUES64 (embryonic stem cells) Permissive Robust Homo sapiens GSE61475 ... MA0148.4
FOXA1 HUES64 (embryonic stem cells) Permissive Robust Homo sapiens GSE61475 ... MA0148.4
FOXA1 F9 (embryonal carcinoma) Permissive Robust Mus musculus GSE82314 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens GSE94001 ... MA0148.4
FOXA1 22RV1 (prostate carcinoma) Permissive Robust Homo sapiens GSE96652 ... MA0148.4
FOXA1 pancreatic ductal adenocarcinoma Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 pancreatic ductal adenocarcinoma Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 pancreatic ductal adenocarcinoma Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 pancreatic ductal adenocarcinoma, liver metastasis Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 pancreatic ductal adenocarcinoma, peritoneum metastasis Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 pancreatic ductal adenocarcinoma, peritoneum metastasis Permissive Robust Mus musculus GSE99284 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens GSE25710 ... MA0148.4
FOXA1 ZR-75-1 (invasive ductal carcinoma) Permissive Robust Homo sapiens GSE25710 ... MA0148.4
FOXA1 T47D (invasive ductal carcinoma) Permissive Robust Homo sapiens GSE25710 ... MA0148.4
FOXA1 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Permissive Robust Homo sapiens GSE25710 ... MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens GSE25710 ... MA0148.4
FOXA1 liver Permissive Robust Homo sapiens ENCSR324RCI MA0148.4
FOXA1 HepG2 (hepatoblastoma) Permissive Robust Homo sapiens ENCSR267DFA MA0148.4
FOXA1 liver Permissive Robust Homo sapiens ENCSR735KEY MA0148.4
FOXA1 HEK293T (embryonic kidney) Permissive Robust Homo sapiens ENCSR094WHO MA0148.4
FOXA1 LNCaP (prostate carcinoma) Permissive Robust Homo sapiens ERP001226 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens ERP001226 MA0148.4
FOXA1 MDA-MB-453 (breast adenocarcinoma) Permissive Robust Homo sapiens ERP001226 MA0148.4
FOXA1 liver Permissive Robust Homo sapiens ERP002306 MA0148.4
FOXA1 Permissive Robust Homo sapiens ERP003828 MA0148.4
FOXA1 Permissive Robust Homo sapiens ERP003828 MA0148.4
FOXA1 Permissive Robust Homo sapiens ERP003828 MA0148.4
FOXA1 NCI-H3122 (lung adenocarcinoma) Permissive Robust Homo sapiens GSE39998 MA0148.4
FOXA1 LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE52725 MA0148.4
FOXA1 LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE56288 MA0148.4
FOXA1 LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE64656 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens GSE80808 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) E2_TAM Permissive Robust Homo sapiens ERP000380 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) TAMR_E2_TAM Permissive Robust Homo sapiens ERP000380 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) E2 Permissive Robust Homo sapiens GSE23852 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) ETOH Permissive Robust Homo sapiens GSE23852 MA0148.4
FOXA1 LNCaP (prostate carcinoma) DHT Permissive Robust Homo sapiens GSE28264 MA0148.4
FOXA1 LNCaP (prostate carcinoma) ETOH Permissive Robust Homo sapiens GSE28264 MA0148.4
FOXA1 LNCaP (prostate carcinoma) 1F5 Permissive Robust Homo sapiens GSE30623 MA0148.4
FOXA1 LNCaP (prostate carcinoma) 1F5_SIFOXA1 Permissive Robust Homo sapiens GSE30623 MA0148.4
FOXA1 LNCaP (prostate carcinoma) SHCTR_R1881 Permissive Robust Homo sapiens GSE37345 MA0148.4
FOXA1 LNCaP (prostate carcinoma) SHFOXA1_R1881 Permissive Robust Homo sapiens GSE37345 MA0148.4
FOXA1 HuH7 (hepatocellular carcinoma) ASYNC Permissive Robust Homo sapiens GSE39241 MA0148.4
FOXA1 HuH7 (hepatocellular carcinoma) MITO Permissive Robust Homo sapiens GSE39241 MA0148.4
FOXA1 LNCaP C4-2B (prostate carcinoma) DHT Permissive Robust Homo sapiens GSE40050 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) SICTR Permissive Robust Homo sapiens GSE40129 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) SIGATA Permissive Robust Homo sapiens GSE40129 MA0148.4
FOXA1 DU145 (prostate carcinoma) FOXA1_ARC562S Permissive Robust Homo sapiens GSE47987 MA0148.4
FOXA1 DU145 (prostate carcinoma) FOXA1_ARQ6540X Permissive Robust Homo sapiens GSE47987 MA0148.4
FOXA1 DU145 (prostate carcinoma) FOXA1_HIGH Permissive Robust Homo sapiens GSE47987 MA0148.4
FOXA1 VCaP (prostate carcinoma) ETOH Permissive Robust Homo sapiens GSE56086 MA0148.4
FOXA1 VCaP (prostate carcinoma) R1881 Permissive Robust Homo sapiens GSE56086 MA0148.4
FOXA1 VCaP (prostate carcinoma) SHCTR_R1881 Permissive Robust Homo sapiens GSE56086 MA0148.4
FOXA1 VCaP (prostate carcinoma) SHPIAS1_R1881 Permissive Robust Homo sapiens GSE56086 MA0148.4
FOXA1 LNCaP (prostate carcinoma) DHT24H Permissive Robust Homo sapiens GSE58428 MA0148.4
FOXA1 LNCaP (prostate carcinoma) ETOH24H Permissive Robust Homo sapiens GSE58428 MA0148.4
FOXA1 VCaP (prostate carcinoma) DHT24H Permissive Robust Homo sapiens GSE58428 MA0148.4
FOXA1 VCaP (prostate carcinoma) ETOH24H Permissive Robust Homo sapiens GSE58428 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) E2 Permissive Robust Homo sapiens GSE59530 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) E2_TNF Permissive Robust Homo sapiens GSE59530 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) TNF Permissive Robust Homo sapiens GSE59530 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) E2 Permissive Robust Homo sapiens GSE60270 MA0148.4
FOXA1 LNCaP-abl (Prostate carcinoma) SHCREB1 Permissive Robust Homo sapiens GSE63034 MA0148.4
FOXA1 LNCaP-abl (Prostate carcinoma) SHCTR Permissive Robust Homo sapiens GSE63034 MA0148.4
FOXA1 KOKLF5 Permissive Robust Homo sapiens GSE64557 MA0148.4
FOXA1 SHCTR Permissive Robust Homo sapiens GSE64557 MA0148.4
FOXA1 LNCaP (prostate carcinoma) ETOH Permissive Robust Homo sapiens GSE69043 MA0148.4
FOXA1 LNCaP (prostate carcinoma) PHFRPMIFCS Permissive Robust Homo sapiens GSE69043 MA0148.4
FOXA1 LNCaP (prostate carcinoma) R1881 Permissive Robust Homo sapiens GSE69043 MA0148.4
FOXA1 LNCaP (prostate carcinoma) SHGATA2_ETOH Permissive Robust Homo sapiens GSE69043 MA0148.4
FOXA1 LNCaP (prostate carcinoma) SHGATA2_R1881 Permissive Robust Homo sapiens GSE69043 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) DEX Permissive Robust Homo sapiens GSE72249 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) E2 Permissive Robust Homo sapiens GSE72249 MA0148.4
FOXA1 T47D (invasive ductal carcinoma) DEX Permissive Robust Homo sapiens GSE72249 MA0148.4
FOXA1 T47D (invasive ductal carcinoma) E2 Permissive Robust Homo sapiens GSE72249 MA0148.4
FOXA1 ZR-75-1 (invasive ductal carcinoma) DEX Permissive Robust Homo sapiens GSE72249 MA0148.4
FOXA1 ZR-75-1 (invasive ductal carcinoma) E2 Permissive Robust Homo sapiens GSE72249 MA0148.4
FOXA1 LNCaP (prostate carcinoma) DHT Permissive Robust Homo sapiens GSE83860 MA0148.4
FOXA1 LNCaP (prostate carcinoma) DHT_TNFA Permissive Robust Homo sapiens GSE83860 MA0148.4
FOXA1 LNCaP (prostate carcinoma) DMSO Permissive Robust Homo sapiens GSE83860 MA0148.4
FOXA1 LNCaP (prostate carcinoma) TNFA Permissive Robust Homo sapiens GSE83860 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens ERP000380 MA0148.4
FOXA1 LNCaP C4-2B (prostate carcinoma) Permissive Robust Homo sapiens GSE40050 MA0148.4
FOXA1 DU145 (prostate carcinoma) Permissive Robust Homo sapiens GSE47987 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens GSE59530 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens GSE60270 MA0148.4
FOXA1 LNCaP-abl (Prostate carcinoma) Permissive Robust Homo sapiens GSE63034 MA0148.4
FOXA1 MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens GSE72249 MA0148.4
FOXA1 T47D (invasive ductal carcinoma) Permissive Robust Homo sapiens GSE72249 MA0148.4
FOXA1 ZR-75-1 (invasive ductal carcinoma) Permissive Robust Homo sapiens GSE72249 MA0148.4